Abstract
Dr. Joshua Sharfstein, Marisa North, and Dr. Janet Serwint write that, in October, an FDA advisory committee voted in favor of immediate action against the use of cough and cold medications in children under 6. After the meeting, the major manufacturers of these products announced that they would continue to market these preparations for children between 2 and 5 years of age.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
